Ian Roy Johnson is a British businessperson who founded Biotrace International Plc and who has been at the helm of 14 different companies. Presently, he occupies the position of Independent Non-Executive Chairman of Redcentric Plc and Executive Chairman for Circassia Group Plc. Mr. Johnson is also on the board of Circassia Ltd., Clinigen Group Plc and Klenitise Ltd. and Member of The Institute of Directors, Member of Institute of Biology and Member of Royal Society of Biology.
Mr. Johnson previously was Non-Executive Chairman for Ascendx Spine, Inc., Chairman for Newcrest Mining Ltd., Chairman at Biofortuna Ltd., Non-Executive Chairman of Cyprotex Ltd., Non-Executive Chairman for EAG Ltd., Executive Chairman at Bioquell Ltd., Chairman for Development Bank of Wales Plc, Chairman at Evans Analytical Group LLC, Chairman of Lumora Ltd., Non-Executive Chairman at Celsis Group Ltd., Non-Executive Chairman of Quantum Pharma Holdings Ltd. and Chief Executive Officer at Biotrace International Plc.
Mr. Johnson received an undergraduate degree and a graduate degree from the University of Cardiff.